Skip to main content

Together we are beating cancer

Donate now

Phil Prime

Showing 12 out of 68 results
Simon-Boulton-and-Kairbaan-Hodivala-Dilke

We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs. We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs.

by Phil Prime | Interview | 22 November 2022

22 November 2022

This entry is part 1 of 8 in the series Diversity in research

This episode features our Chief Clinician Professor Charles Swanton. He talks about lung cancer, the power of the translational mind-set and delves into the flagship project, TRACERx. This episode features our Chief Clinician Professor Charles Swanton. He talks about lung cancer, the power of the translational mind-set and delves into the flagship project, TRACERx.

by Phil Prime | Podcast | 1 November 2022

1 November 2022

This entry is part 7 of 9 in the series Cancer Research Matters - series 1
This entry is part 2 of 8 in the series Diversity in research

Developing treatments and diagnostics from your research really is the best way to create patient impact says radiation biologist Professor Catharine West... Developing treatments and diagnostics from your research really is the best way to create patient impact says radiation biologist Professor Catharine West...

by Phil Prime | Interview | 17 October 2022

17 October 2022

As newly appointed chief scientist for Cancer Research UK, Professor KJ Patel brings a wealth of expertise and experience. As newly appointed chief scientist for Cancer Research UK, Professor KJ Patel brings a wealth of expertise and experience.

by Phil Prime | Interview | 12 October 2022

12 October 2022

We hear from the Excellence in Cancer Research Nursing Award shortlisted nurses about their work and the vital role they play in delivering clinical trials... We hear from the Excellence in Cancer Research Nursing Award shortlisted nurses about their work and the vital role they play in delivering clinical trials...

by Phil Prime | In depth | 7 October 2022

7 October 2022

A newly merged biobank will be UK’s leading biomedical research resource dedicated to storing samples and data of cancers in children and young people - we explore its potential impact... A newly merged biobank will be UK’s leading biomedical research resource dedicated to storing samples and data of cancers in children and young people - we explore its potential impact...

by Phil Prime | Interview | 27 September 2022

27 September 2022

The theme for this year’s Peer Review Week is ‘research integrity’ – that really strikes a chord with our new columnists… The theme for this year’s Peer Review Week is ‘research integrity’ – that really strikes a chord with our new columnists…

by Phil Prime | Analysis | 21 September 2022

21 September 2022

This entry is part 8 of 13 in the series Research Integrity

This episode features Professor Richard Gilbertson. Richard is a paediatric oncology clinician scientist and is the Director of the Cancer Research UK Cambridge Centre. He talks about the challenges and successes of the childhood cancer research community, how he sees the future of the field and some of the incredible breakthroughs his lab has made on childhood brain cancers. This episode features Professor Richard Gilbertson. Richard is a paediatric oncology clinician scientist and is the Director of the Cancer Research UK Cambridge Centre. He talks about the challenges and successes of the childhood cancer research community, how he sees the future of the field and some of the incredible breakthroughs his lab has made on childhood brain cancers.

by Phil Prime | Podcast | 6 September 2022

6 September 2022

This entry is part 6 of 9 in the series Cancer Research Matters - series 1

This episode features outgoing CRUK Chief Scientist, Professor Karen Vousden. Known for her work on the tumour suppressor protein, p53, she has also worked on HPV and cancer metabolism. She talks about the success and challenges of work around p53, her joy at being involved in the early work around HPV, the frustrations of coming so close to a huge breakthrough and how life as a researcher has changed. This episode features outgoing CRUK Chief Scientist, Professor Karen Vousden. Known for her work on the tumour suppressor protein, p53, she has also worked on HPV and cancer metabolism. She talks about the success and challenges of work around p53, her joy at being involved in the early work around HPV, the frustrations of coming so close to a huge breakthrough and how life as a researcher has changed.

by Phil Prime | Podcast | 25 August 2022

25 August 2022

This entry is part 5 of 9 in the series Cancer Research Matters - series 1

We catch up with Dr Alexis Webb and find out about the upcoming Early Detection of Cancer Conference, the importance of collaboration and why these are exciting times for the field... We catch up with Dr Alexis Webb and find out about the upcoming Early Detection of Cancer Conference, the importance of collaboration and why these are exciting times for the field...

by Phil Prime | Interview | 18 August 2022

18 August 2022